Molecular Partners AG announced earnings results for the half year ended June 30, 2021. For the half year, the company announced total revenue was CHF 4.417 million compared to CHF 7.516 million a year ago. Operating loss was CHF 34.793 million compared to CHF 23.092 million a year ago. Net loss was CHF 33.567 million compared to CHF 24.748 million a year ago. Basic loss per share from continuing operations was CHF 1.13 compared to CHF 1.14 a year ago.